{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:50:40Z","timestamp":1792399840298,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01157-2","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:00:59Z","timestamp":1749128459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of a suspension Vero cell line for viral vaccine production"],"prefix":"10.1038","volume":"10","author":[{"given":"L\u00e9a","family":"Bourigault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Bresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chevalard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Kloutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleurine","family":"Pelissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bassard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Charretier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-8444","authenticated-orcid":false,"given":"Bertrand","family":"Pain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"1157_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12992-016-0195-3","volume":"12","author":"SF Hussain","year":"2016","unstructured":"Hussain, S. F., Boyle, P., Patel, P. & Sullivan, R. Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue. Glob. Health 12, 63 (2016).","journal-title":"Glob. Health"},{"key":"1157_CR2","unstructured":"Meeting, W.E.C.o.B.S. & Standardization, W.H.O.E.C.o.B. WHO Expert Committee on Biological Standardization: Sixty-first Report, Vol. 978. (World Health Organization, 2013)."},{"key":"1157_CR3","first-page":"1201","volume":"21","author":"Y Yasumura","year":"1963","unstructured":"Yasumura, Y. & Kawakita, Y. Studies on SV40 in tissue culture-preliminary step for cancer research in vitro. Nihon Rinsho 21, 1201\u20131215 (1963).","journal-title":"Nihon Rinsho"},{"key":"1157_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/dnares\/dsu029","volume":"21","author":"N Osada","year":"2014","unstructured":"Osada, N. et al. The genome landscape of the african green monkey kidney-derived Vero cell line. DNA Res. 21, 673\u2013683 (2014).","journal-title":"DNA Res."},{"key":"1157_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.020","volume":"193","author":"DH Vlecken","year":"2013","unstructured":"Vlecken, D. H., Pelgrim, R. P., Ruminski, S., Bakker, W. A. & van der Pol, L. A. Comparison of initial feasibility of host cell lines for viral vaccine production. J. Virol. Methods 193, 28\u201341 (2013).","journal-title":"J. Virol. Methods"},{"key":"1157_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/21645515.2015.1016666","volume":"11","author":"NR Hegde","year":"2015","unstructured":"Hegde, N. R. Cell culture-based influenza vaccines: a necessary and indispensable investment for the future. Hum. Vaccin Immunother. 11, 1223\u20131234 (2015).","journal-title":"Hum. Vaccin Immunother."},{"key":"1157_CR7","unstructured":"Duigou, A. Ma\u00eetrise des proc\u00e9d\u00e9s de culture cellulaire pour la production de vaccins. Doctoral dissertation, UHP-Universit\u00e9 Henri Poincar\u00e9 (2010)."},{"key":"1157_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/biol.1998.0153","volume":"26","author":"V Grachev","year":"1998","unstructured":"Grachev, V., Magrath, D., Griffiths, E. & Petricciani, J. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No. 50). Biologicals 26, 175\u2013193 (1998).","journal-title":"Biologicals"},{"key":"1157_CR9","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1016\/j.vaccine.2009.06.020","volume":"27","author":"C Paillet","year":"2009","unstructured":"Paillet, C., Forno, G., Kratje, R. & Etcheverrigaray, M. Suspension-Vero cell cultures as a platform for viral vaccine production. Vaccine 27, 6464\u20136467 (2009).","journal-title":"Vaccine"},{"key":"1157_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-4939-7312-5_6","volume":"1674","author":"AL Caron","year":"2018","unstructured":"Caron, A. L., Biaggio, R. T. & Swiech, K. Strategies to Suspension Serum-Free Adaptation of Mammalian Cell Lines for Recombinant Glycoprotein Production. Methods Mol. Biol. 1674, 75\u201385 (2018).","journal-title":"Methods Mol. Biol."},{"key":"1157_CR11","doi-asserted-by":"publisher","first-page":"107868","DOI":"10.1016\/j.bej.2020.107868","volume":"167","author":"R-M Comisel","year":"2021","unstructured":"Comisel, R.-M., Kara, B., Fiesser, F. H. & Farid, S. S. Lentiviral vector bioprocess economics for cell and gene therapy commercialization. Biochem. Eng. J. 167, 107868 (2021).","journal-title":"Biochem. Eng. J."},{"key":"1157_CR12","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1016\/j.vaccine.2019.05.092","volume":"37","author":"S Rourou","year":"2019","unstructured":"Rourou, S., Ben Zakkour, M. & Kallel, H. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Vaccine 37, 6987\u20136995 (2019).","journal-title":"Vaccine"},{"key":"1157_CR13","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1016\/j.vaccine.2019.07.003","volume":"37","author":"CF Shen","year":"2019","unstructured":"Shen, C. F. et al. Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Vaccine 37, 6996\u20137002 (2019).","journal-title":"Vaccine"},{"key":"1157_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7774\/cevr.2020.9.1.48","volume":"9","author":"DK Lee","year":"2020","unstructured":"Lee, D. K., Park, J. & Seo, D. W. Suspension culture of Vero cells for the production of adenovirus type 5. Clin. Exp. Vaccin. Res. 9, 48\u201355 (2020).","journal-title":"Clin. Exp. Vaccin. Res."},{"key":"1157_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10221-z","volume":"12","author":"M Logan","year":"2022","unstructured":"Logan, M., Rinas, K., McConkey, B. & Aucoin, M. G. Vero cells gain renal tubule markers in low-calcium and magnesium chemically defined media. Sci. Rep. 12, 6180 (2022).","journal-title":"Sci. Rep."},{"key":"1157_CR16","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/bit.27785","volume":"118","author":"S Kiesslich","year":"2021","unstructured":"Kiesslich, S., Kim, G. N., Shen, C. F., Kang, C. Y. & Kamen, A. A. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures. Biotechnol. Bioeng. 118, 2649\u20132659 (2021).","journal-title":"Biotechnol. Bioeng."},{"key":"1157_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/vaccines9111335","volume":"9","author":"JPC Fulber","year":"2021","unstructured":"Fulber, J. P. C. et al. Process development for Newcastle disease virus-vectored vaccines in serum-free Vero cell suspension cultures. Vaccines 9, 1335 (2021).","journal-title":"Vaccines"},{"key":"1157_CR18","doi-asserted-by":"publisher","first-page":"e2300244","DOI":"10.1002\/biot.202300244","volume":"19","author":"CF Shen","year":"2023","unstructured":"Shen, C. F. et al. Development, optimization, and scale-up of suspension Vero cell culture process for high-titer production of oncolytic herpes simplex virus-1. Biotechnol. J. 19, e2300244 (2023).","journal-title":"Biotechnol. J."},{"key":"1157_CR19","unstructured":"Petiot, E. Proc\u00e9d\u00e9s de cultures de cellules VERO en milieu sans s\u00e9rum : contributions au d\u00e9veloppement d'une strat\u00e9gie PAT. Institut Polytechnique de Lorraine (2009)."},{"key":"1157_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026185615650","volume":"42","author":"S Quesney","year":"2003","unstructured":"Quesney, S. et al. Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium. Cytotechnology 42, 1\u201311 (2003).","journal-title":"Cytotechnology"},{"key":"1157_CR21","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2007.01.086","volume":"25","author":"S Rourou","year":"2007","unstructured":"Rourou, S., van der Ark, A., van der Velden, T. & Kallel, H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 25, 3879\u20133889 (2007).","journal-title":"Vaccine"},{"key":"1157_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF02922022","volume":"30","author":"T Hassell","year":"1991","unstructured":"Hassell, T., Gleave, S. & Butler, M. Growth inhibition in animal cell culture: The effect of lactate and ammonia. Appl. Biochem. Biotechnol. 30, 29\u201341 (1991).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"1157_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s004490050433","volume":"18","author":"RZ Mendon\u00e7a","year":"1998","unstructured":"Mendon\u00e7a, R. Z. & Pereira, C. Cell metabolism and medium perfusion in VERO cell cultures on microcarriers in a bioreactor. Bioprocess Eng. 18, 213\u2013218 (1998).","journal-title":"Bioprocess Eng."},{"key":"1157_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1101\/gad.8.4.453","volume":"8","author":"MV Barone","year":"1994","unstructured":"Barone, M. V., Crozat, A., Tabaee, A., Philipson, L. & Ron, D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1\/S arrest. Genes Dev. 8, 453\u2013464 (1994).","journal-title":"Genes Dev."},{"key":"1157_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1101\/gad.12.7.982","volume":"12","author":"H Zinszner","year":"1998","unstructured":"Zinszner, H. et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982\u2013995 (1998).","journal-title":"Genes Dev."},{"key":"1157_CR26","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M114.635144","volume":"290","author":"RR Crawford","year":"2015","unstructured":"Crawford, R. R. et al. Human CHAC1 protein degrades glutathione, and mRNA induction is regulated by the transcription factors ATF4 and ATF3 and a bipartite ATF\/CRE regulatory element. J. Biol. Chem. 290, 15878\u201315891 (2015).","journal-title":"J. Biol. Chem."},{"key":"1157_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4049\/jimmunol.182.1.466","volume":"182","author":"IN Mungrue","year":"2009","unstructured":"Mungrue, I. N., Pagnon, J., Kohannim, O., Gargalovic, P. S. & Lusis, A. J. CHAC1\/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. J. Immunol. 182, 466\u2013476 (2009).","journal-title":"J. Immunol."},{"key":"1157_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/sj.emboj.7600596","volume":"24","author":"N Ohoka","year":"2005","unstructured":"Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K. & Hayashi, H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. Embo J. 24, 1243\u20131255 (2005).","journal-title":"Embo J."},{"key":"1157_CR29","doi-asserted-by":"publisher","first-page":"9364689","DOI":"10.1155\/2023\/9364689","volume":"2023","author":"MA S\u00e8ne","year":"2023","unstructured":"S\u00e8ne, M. A., Xia, Y. & Kamen, A. A. Comparative transcriptomic analyses of a vero cell line in suspension versus adherent culture conditions. Int J. Cell Biol. 2023, 9364689 (2023).","journal-title":"Int J. Cell Biol."},{"key":"1157_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76137-8","volume":"10","author":"M Malm","year":"2020","unstructured":"Malm, M. et al. Evolution from adherent to suspension: systems biology of HEK293 cell line development. Sci. Rep. 10, 18996 (2020).","journal-title":"Sci. Rep."},{"key":"1157_CR31","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","volume":"271","author":"DM Ornitz","year":"1996","unstructured":"Ornitz, D. M. et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292\u201315297 (1996).","journal-title":"J. Biol. Chem."},{"key":"1157_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fcell.2017.00058","volume":"5","author":"R Diez del Corral","year":"2017","unstructured":"Diez del Corral, R. & Morales, A. V. The multiple roles of FGF signaling in the developing spinal cord. Front. Cell Dev. Biol. 5, 58 (2017).","journal-title":"Front. Cell Dev. Biol."},{"key":"1157_CR33","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 46, D649\u2013d655 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR35","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"1157_CR36","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060184","volume":"6","author":"AR Pico","year":"2008","unstructured":"Pico, A. R. et al. WikiPathways: pathway editing for the people. PLoS Biol. 6, e184 (2008).","journal-title":"PLoS Biol."},{"key":"1157_CR38","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2009","unstructured":"Schaefer, C. F. et al. PID: the pathway interaction database. Nucleic Acids Res. 37, D674\u2013D679 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1157_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"1157_CR40","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551\u20131566 (2013).","journal-title":"Nat. Protoc."},{"key":"1157_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.4218","volume":"31","author":"PD Thomas","year":"2022","unstructured":"Thomas, P. D. et al. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 31, 8\u201322 (2022).","journal-title":"Protein Sci."},{"key":"1157_CR42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.vaccine.2012.12.046","volume":"31","author":"C Manin","year":"2013","unstructured":"Manin, C. et al. Method for the simultaneous assay of the different poliovirus types using surface plasmon resonance technology. Vaccine 31, 1034\u20131039 (2013).","journal-title":"Vaccine"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01157-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:01:00Z","timestamp":1749128460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01157-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3590769\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following financial interests and personal relationships as potential competing interests: This work was funded by Sanofi. L\u00e9a Bourigault, Corinne Bresson, Christophe Chevalard, Damien Soulet, Fleurine Pelissier, St\u00e9phanie Richard, Isabelle Bassard, Nicolas S\u00e8ve, and C\u00e9dric Charretier are Sanofi employees and may hold shares or stocks in the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}